| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.3 | 8e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |